Alnylam Pharmaceuticals
ALNY
#580
Rank
S$47.46 B
Marketcap
$367.98
Share price
1.91%
Change (1 day)
67.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of September 2024 : S$3.68 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has S$3.68 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$3.22 B9.61%
2022-12-31S$2.93 B-10.74%
2021-12-31S$3.29 B32.78%
2020-12-31S$2.47 B19.73%
2019-12-31S$2.07 B39.83%
2018-12-31S$1.48 B-34.5%
2017-12-31S$2.26 B149.26%
2016-12-31S$0.90 B-40.65%
2015-12-31S$1.52 B66.03%
2014-12-31S$0.92 B195.51%
2013-12-31S$0.31 B107.42%
2012-12-31S$0.15 B-20.79%
2011-12-31S$0.18 B-36.86%
2010-12-31S$0.30 B-23.99%
2009-12-31S$0.39 B-35.81%
2008-12-31S$0.61 B9.69%
2007-12-31S$0.56 B68.43%
2006-12-31S$0.33 B150.1%
2005-12-31S$0.13 B77.32%
2004-12-31S$75.11 M90.63%
2003-12-31S$39.4 M46.73%
2002-12-31S$26.85 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.57 B-84.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.99 B 252.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.93 B-47.47%๐Ÿ‡บ๐Ÿ‡ธ USA
S$53.82 M-98.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.12 B-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.59 B 404.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$9.66 B 162.00%๐Ÿ‡ซ๐Ÿ‡ท France
S$2.99 B-18.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel